Abstract

Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy

Author(s): Rhoads Rick

Issue: Mar/Apr 2018 - Volume 22, Number 2

Page(s): 129-134

Download in electronic PDF format for $75
  • Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy Page 1
  • Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy Page 2
  • Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy Page 3
  • Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy Page 4
  • Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy Page 5
  • Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy Page 6

Abstract

Changes in California regulations regarding beyond-use dates of sterile preparations have prompted many compounders to consider stability studies for their formulas. Traditionally, 503A compounders have relied on published data and professional experience to determine stability. However, due to these new regulations, stability studies are now required for California resident and nonresident licensees to extend the beyond-use date of sterile preparations. Conducting studies for the first time can be costly and difficult for compounding pharmacists. This article shares several lessons learned from the author’s experience performing stability studies on Trimix injection, a sterile preparation for erectile dysfunction. Avoiding easily made errors can save the compounder unnecessary time and expense.

Related Keywords

  • compounded sterile preparations
  • sterile compounding
  • beyond-use dates
  • stability studies
  • Trimix injection
  • erectile dysfunction
  • California Code of Regulations
  • time-point testing
  • bracketing
  • concentration
  • starting material potency
  • pharmacy staff
  • training

Related Categories

  • LEGAL
  • STABILITIES, COMPATIBILITIES
  • STERILE PREPARATIONS
  • QUALITY CONTROL
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2018
Pg. 129-134
Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy
Author(s): Rhoads Rick
Jan/Feb 2021
Pg. 73-81
Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design
Author(s): Patel Gopesh, Davis Countaney, Liu Yi, Ip Kendice, Debideen Krystal E, Anderson Stephanie, Byrne Robert, Herr Dylan, Rhoads Melissa Merrell, Caputo Ross, Banov Daniel, Bassani August S
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 2004
Pg. 231-235
Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction.
Author(s): Trissel Lawrence A, Zhang Yanping
Nov/Dec 2008
Pg. 524-528
Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations
Author(s): Trissel Lawrence A
May/Jun 2010
Pg. 232-238
Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations
Author(s): Okeke Claudia C, Allen Loyd V Jr
Jan/Feb 2021
Pg. 18-23
Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol
Author(s): McKettrick Greg, Yoch Doug
May/Jun 2017
Pg. 193-203
Microbiologic Testing for 503A Sterile-Compounding Pharmacies
Author(s): Mixon William, Roth Abby
Jul/Aug 2018
Pg. 303-312
Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating
Author(s): Martin Matt
Jan/Feb 2018
Pg. 7-16
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies
Author(s): Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
Mar/Apr 2019
Pg. 123-130
Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding?
Author(s): Allen Loyd V Jr
Mar/Apr 2004
Pg. 89-94
Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists
Author(s): Rahe Hank
Mar/Apr 2017
Pg. 95-102
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Author(s): Yoch Doug
Jan/Feb 2014
Pg. 6-12
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Jul/Aug 2013
Pg. 307-311
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations
Author(s): McElhiney Linda F
Sep/Oct 2019
Pg. 399-402
Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding
Author(s): Allen Loyd V Jr
Jul/Aug 2008
Pg. 344-353
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating
Author(s): Allen Loyd V Jr, Okeke Claudia C
May/Jun 2019
Pg. 221-228
Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
Author(s): Allen Loyd V Jr
Nov/Dec 2020
Pg. 460-465
Establishing a Structured Pharmacy Training Program in Sterile Compounding
Author(s): Dirbas Muhannad, AbuSara Aseel K, Whiyabi Shatha, Harb Rema, Telfah Shorouq
Nov/Dec 2012
Pg. 471-474
Beyond-use Date: Establishment and Maintenance
Author(s): Osteen Richard